E-Medicare Pharma
Online Medicine Pharmacy
0.00$
Lenvakin (Lenvatinib) 10 mg is a medication used in the treatment of various cancers, including thyroid cancer and hepatocellular carcinoma (HCC). It belongs to a class of drugs known as receptor tyrosine kinase inhibitors, which work by blocking the activity of specific proteins involved in cancer cell growth and blood vessel formation. Lenvakin 10 mg offers a targeted therapy option for patients with advanced or metastatic cancers, helping to slow tumor progression and improve survival outcomes.
1. Indications:
Lenvakin (Lenvatinib) 10 mg is indicated for the treatment of:
2. Pharmacology:
Lenvakin (Lenvatinib) 10 mg exerts its pharmacological effects by selectively inhibiting multiple receptor tyrosine kinases, including vascular endothelial growth factor receptors (VEGFR), fibroblast growth factor receptors (FGFR), and platelet-derived growth factor receptors (PDGFR). By blocking these signaling pathways, Lenvakin inhibits angiogenesis (the formation of new blood vessels) and tumor cell proliferation, ultimately leading to tumor regression and inhibition of cancer progression.
3. Dosage and Administration:
The recommended dosage of Lenvakin (Lenvatinib) 10 mg may vary depending on the type of cancer being treated and individual patient characteristics. Typically, the prescribed dose is 10 mg taken orally once daily, with or without food. Treatment should continue until disease progression, unacceptable toxicity, or other treatment discontinuation criteria are met. Dose adjustments or discontinuation may be necessary based on individual patient response and tolerability.
4. Interaction:
Lenvakin (Lenvatinib) 10 mg may interact with other medications, including:
Patients should inform their healthcare provider about all medications they are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions.
5. Side Effects:
Common side effects associated with Lenvakin (Lenvatinib) 10 mg may include:
Patients should report any persistent or severe side effects to their healthcare provider for further evaluation and management.
6. Precautions and Warnings:
Before using Lenvakin (Lenvatinib) 10 mg, patients should be aware of the following precautions:
7. Overdose Effects:
In case of overdose with Lenvakin (Lenvatinib) 10 mg, supportive care should be initiated, and symptomatic treatment may be administered as necessary. There is no specific antidote for Lenvakin overdose, and patients should seek immediate medical attention if overdose is suspected.
Generic Name: | Lenvatinib |
---|---|
Theraputic Category: | Anti-Cancer |
Pack Size: | 4 mg, 10 mg – 30's |
Previous Product
Next Product
Begin your journey to better health . Join now to unlock exclusive tips and insights sent straight to your inbox, empowering you to embrace a healthier lifestyle each and every day.
Online Medicine Pharmacy
+8801929123476 emedicarepharma@gmail.com
65, mymansingh High-way, Dhaka-1230, Bangladesh